Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Enteromicro Complex is a symbiotic nutritional supplement for veterinary use in dogs and cats, developed by Nextmune. [3, 5] It is designed to support intestinal health and restore the balance of gut microflora, particularly during periods of dietary changes, stress, or following medication use. [4, 16] The product is a combination of probiotics, prebiotics, and other functional ingredients. Its mechanism involves replenishing beneficial gut bacteria with probiotics like microencapsulated *Enterococcus faecium* (strain NCIMB 10415), while prebiotics such as Fructo-oligosaccharides (FOS) and Mannan-oligosaccharides (MOS) nourish the native microbiome. [7, 8, 9] Additional components include bovine colostrum to support the immune system, pectins to help form solid stools and protect the intestinal lining, and plant extracts like fennel (*Foeniculum vulgare*) and blackberry (*Rubus fruticosus*) to soothe the gastrointestinal tract. [2, 6, 7] Enteromicro Complex is available in oral tablet and paste formulations. [2, 3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enteromicro Complex.